Biodexa Pharmaceuticals Plc
BDRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001643918
No open-market purchases or sales by Biodexa Pharmaceuticals Plc insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $48.1K in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Biodexa Pharmaceuticals Plc changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 7 | 8 | +1 |
| Shares | 185.8K | 670.5K | +484.7K (+260.8%) |
| Value | $72.0K | $45.8K | −$26.2K (−36.4%) |
New holders (5)
Institutions that held Biodexa Pharmaceuticals Plc at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cubist Systematic Strategies, LLC | 265,993 | $18.2K | 0.00% |
| UBS Group AG | 142,208 | $9.81K | 0.00% |
| Two Sigma Securities, LLC | 37,865 | $2.60K | 0.00% |
| Baader Bank INC | 16,250 | $865 | 0.00% |
| Rhumbline Advisers | 2,370 | $163 | 0.00% |
Sold out (4)
Institutions that held Biodexa Pharmaceuticals Plc at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Renaissance Technologies LLC | 53,016 | $21.0K |
| Virtu Financial LLC | 47,289 | $18.0K |
| CVI Holdings, LLC | 30,611 | $11.9K |
| Kingsview Wealth Management, LLC | 16,647 | $6.49K |